With the deep analysis of the above alternatives, it is suggested that the business must choose the alternative 3 in order to preserve a competitive position in the long run. As the alternative 3 would allow the company to not just introduce brand-new and innovative items in the market it would also reduce the high expenditures on R&D under alternative 2 and increase the revenue margins. It would enable the business to increase its share prices also, as financiers want to invest more in business with significant R&D spending and boost in the overall worth of the company.
Action and implementation Strategy
Strategy can be carried out effectively by developing particular short-term along with long term plans. These plans could be as follows;
Short Term Plan (0-1 year)
• Under the short-term plan Corporate Venture Capital At Eli Lilly ought to perform various activities to execute its NHW technique efficiently. These activities are as follows;.
• Get the audit of its brand name portfolio done, to examine the core selling brands, which create the majority of its revenue.
• Analyze the current target audience as well as the marketplace segment which is not consist of in the company's circle.
• Analyze the existing financial information to measure the quantity that needs to be invested in the R&D and acquisitions.
• Evaluate the potential financiers and their nature, i.e. do they want long term advantages (capital gain), or the want early revenues (dividend). It would let the company to understand that how much amount should be spent on R&D.
Mid Term Plan (1-5 years)
• Obtain those organizations in which the company has possible experience to handle. Acquire most beneficial companies with a strong dedication to health, to construct the client's understandings in the ideal direction.
• Focus more on acquisitions than R&D to develop the base in the consumer's mind about Corporate Venture Capital At Eli Lilly worths and vision and to avoid potential danger of sunk cost.
Long Term Plan (1-10 years)
• Get organizations with health in addition to taste factor, as the base for the Corporate Venture Capital At Eli Lilly as a business producing healthy items has been developed under midterm plan and now the company could move towards taste factor as well to grasp the customers, which focus more on taste instead of health.
• Be more aggressive towards R&D than the acquisitions, as it is the considerable time to develop new items.
